Key result
Test-negative design yields EV-71 vaccine effectiveness estimates similar to randomized trial findings.
Why the study?
The validity of the test-negative design application in evaluating EV-71 vaccine effectiveness has not been evaluated.
Does the test-negative design validly estimate EV-71 vaccine effectiveness compared to randomized controlled trial results?
RCT (n=7,325)
randomized
Does the test-negative design validly estimate EV-71 vaccine effectiveness compared to randomized controlled trial results?
The test-negative design is a valid observational method to measure EV-71 vaccine effectiveness, yielding estimates similar to those from randomized controlled trials.
Answers are grounded in this paper and cite their sources.
Supports test-negative design for real-world EV-71 vaccine effectiveness estimates; extends observational validation beyond randomized trials.
Background: The test-negative design has been used widely in evaluation of various vaccines’ effectiveness, such as influenza, rotavirus, and so on. Recently, there have been some studies about EV-71 vaccine effectiveness by using test-negative design(TND). However, the validity of the TND application in EV-71 vaccines has not been evaluated.Methods: This study is set upon prior methods to evaluate the validity of TND for influenza vaccine by using a randomized controlled clinical trial database. Vaccine effectiveness estimated by TND (VE-TND) in modified intention-to-treat population (mITT) and per-protocol-set population(PPS) was derived from a large randomized placebo-controlled clinical trial (RCT) of inactivated monovalent EV-71 vaccine in China. Derived VE-TND estimates were compared to the original vaccine efficacy results in RCT (VE-RCT).Results: We totally enrolled 7325 participants who seeked medical care for suspected EV-71 infected diseases during the surveillance. There are no significant differences between cases(test-positive) and controls(test-negative) on sex, age, height, and weight. TND vaccine effectiveness estimates were similar to original RCT vaccine efficacy estimates, both in modified intention-to-treat population and per-protocol populations.Conclusions: This study supports that TND, as an appropriate observational study design is valid to measure EV-71 vaccine effectiveness.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) conducted an RCT in Suspected EV-71 infected diseases (n=7,325). Inactivated monovalent EV-71 vaccine vs. Placebo was evaluated on Vaccine effectiveness. In 7,325 participants, test-negative design vaccine effectiveness estimates for the EV-71 vaccine were similar to original randomized controlled trial vaccine efficacy estimates.
Synapse has enriched 10 related papers. Consider them for comparative context: